Human-brain FTD samples and controls acquired postmortem offer a unique window into molecular disease characteristics, both systemically and in cells with TDP-43 pathology,18 but retrieving cell-type-specific splicing information out of frozen-brain collections has historically been difficult. This evidence concerns the gene TARDBP and frontotemporal dementia.